These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37817028)

  • 1. N
    Tang B; Bi L; Xu Y; Cao L; Li X
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37817028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
    Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
    Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Luo F; Lin K
    Exp Cell Res; 2022 Aug; 417(1):113176. PubMed ID: 35489385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Wang Y; Jin P; Wang X
    Apoptosis; 2024 Feb; 29(1-2):142-153. PubMed ID: 37698736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment.
    Liu Y; Guo Q; Yang H; Zhang XW; Feng N; Wang JK; Liu TT; Zeng KW; Tu PF
    ACS Cent Sci; 2022 Aug; 8(8):1102-1115. PubMed ID: 36032766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Jiang T; Xia Y; Li Y; Lu C; Lin J; Shen Y; Lv J; Xie L; Gu C; Xu Z; Wang L
    Cancer Lett; 2024 Jan; 581():216510. PubMed ID: 38029830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M
    Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
    Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
    Ding N; Cao G; Wang Z; Xu S; Chen W
    Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRPPRC facilitates tumor progression and immune evasion through upregulation of m
    Wang H; Tang A; Cui Y; Gong H; Li H
    Front Immunol; 2023; 14():1144774. PubMed ID: 37063837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
    Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
    [No Abstract]   [Full Text] [Related]  

  • 14. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.
    Liang X; Gao H; Xiao J; Han S; He J; Yuan R; Yang S; Yao C
    Front Immunol; 2023; 14():1185985. PubMed ID: 37334368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Yuan B; Zhou J
    PeerJ; 2023; 11():e14591. PubMed ID: 36691477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Liang A; Liu J; Wei Y; Liao Y; Wu F; Ruan J; Li J
    PeerJ; 2023; 11():e14954. PubMed ID: 37009154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression.
    Li B; Wang B
    Immunol Invest; 2022 Oct; 51(7):1921-1937. PubMed ID: 35852892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
    Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
    Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2BP1 Bolsters the Chondrocytes Ferroptosis of Osteoarthritis by Targeting m
    Zhao Z; Dong S; Yang Y; Yin H; Xiong G; Ma J
    Int J Gen Med; 2024; 17():2433-2443. PubMed ID: 38826510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.